Annual Cash & Cash Equivalents
$25.12 M
-$45.91 M-64.63%
31 December 2023
Summary:
Finch Therapeutics annual cash & cash equivalents is currently $25.12 million, with the most recent change of -$45.91 million (-64.63%) on 31 December 2023. During the last 3 years, it has fallen by -$74.59 million (-74.80%). FNCH annual cash & cash equivalents is now -81.18% below its all-time high of $133.48 million, reached on 31 December 2021.FNCH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$16.04 M
-$4.73 M-22.77%
30 June 2024
Summary:
Finch Therapeutics quarterly cash and cash equivalents is currently $16.04 million, with the most recent change of -$4.73 million (-22.77%) on 30 June 2024. Over the past year, it has dropped by -$12.74 million (-44.28%). FNCH quarterly cash and cash equivalents is now -91.69% below its all-time high of $193.02 million, reached on 31 March 2021.FNCH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.6% | -44.3% |
| 3 y3 years | -74.8% | -89.3% |
| 5 y5 years | - | - |
FNCH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -81.2% | at low | -89.3% | at low |
| 5 y | 5 years | -81.2% | at low | -91.7% | at low |
| alltime | all time | -81.2% | at low | -91.7% | at low |
Finch Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $16.04 M(-22.8%) |
| Mar 2024 | - | $20.76 M(-17.4%) |
| Dec 2023 | $25.12 M(-64.6%) | $25.12 M(-12.7%) |
| Sept 2023 | - | $28.78 M(-15.5%) |
| June 2023 | - | $34.05 M(-18.3%) |
| Mar 2023 | - | $41.68 M(-41.3%) |
| Dec 2022 | $71.04 M | $71.04 M(-16.7%) |
| Sept 2022 | - | $85.29 M(-18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $104.67 M(-2.1%) |
| Mar 2022 | - | $106.93 M(-19.9%) |
| Dec 2021 | $133.48 M(+33.9%) | $133.48 M(-10.5%) |
| Sept 2021 | - | $149.20 M(-11.3%) |
| June 2021 | - | $168.14 M(-12.9%) |
| Mar 2021 | - | $193.02 M(+93.6%) |
| Dec 2020 | $99.71 M(+136.4%) | $99.71 M |
| Dec 2019 | $42.19 M | - |
FAQ
- What is Finch Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Finch Therapeutics?
- What is Finch Therapeutics annual cash & cash equivalents year-on-year change?
- What is Finch Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Finch Therapeutics?
- What is Finch Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Finch Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of FNCH is $25.12 M
What is the all time high annual cash & cash equivalents for Finch Therapeutics?
Finch Therapeutics all-time high annual cash & cash equivalents is $133.48 M
What is Finch Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, FNCH annual cash & cash equivalents has changed by -$45.91 M (-64.63%)
What is Finch Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FNCH is $16.04 M
What is the all time high quarterly cash and cash equivalents for Finch Therapeutics?
Finch Therapeutics all-time high quarterly cash and cash equivalents is $193.02 M
What is Finch Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, FNCH quarterly cash and cash equivalents has changed by -$12.74 M (-44.28%)